Ryvu Therapeutics Named Warsaw Stock Exchange Company of the Year for 2022 Thumbnail Image Read more about Ryvu Therapeutics Named Warsaw Stock Exchange Company of the Year for 2022
Carisma Therapeutics Closes Merger with Sesen Bio Thumbnail Image Read more about Carisma Therapeutics Closes Merger with Sesen Bio
Increase Access to Care and Services among Veterans with a Hematologic Malignancy Thumbnail Image Read more about Increase Access to Care and Services among Veterans with a Hematologic Malignancy
Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program® Thumbnail Image Read more about Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program®
Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-mutant AML Thumbnail Image Read more about Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-mutant AML
Encouraging Additional Data for Bexmarilimab for the Treatment of Hematological Malignancies Thumbnail Image Read more about Encouraging Additional Data for Bexmarilimab for the Treatment of Hematological Malignancies
BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment Thumbnail Image Read more about BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment
